Zhiwen Yang
State Key Laboratory Of Oncology In South China And Collaborative Innovation Center For Cancer Medicine
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Correction to "Antiangiogenesis Combined with Inhibition of the Hypoxia Pathway Facilitates Low-Dose, X-ray-Induced Photodynamic Therapy".
Journal: ACS nano
Published: December 17, 2025
The ameliorative effects of fermented Chinese herbal medicine on growth inhibition and liver damage induced by manganese exposure in largemouth bass (Micropterus salmoides).
Journal: Fish physiology and biochemistry
Published: March 07, 2025
Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 19, 2024
Intra-arterial lidocaine improves long-term survival in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolisation: a retrospective propensity score-matched study.
Journal: British journal of anaesthesia
Published: July 31, 2024
Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma.
Journal: Cancer cell international
Published: August 09, 2023
TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study.
Journal: International journal of surgery (London, England)
Published: September 11, 2022
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.
Journal: Nature communications
Published: May 31, 2022
S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 15, 2022
Correction to: Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 18, 2022
Long-term effects of total vs. partial pancreatectomy among patients with pancreatic cancer: a population-based study.
Journal: Annals of translational medicine
Published: March 02, 2022
Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 14, 2020
Last Updated: 09/26/2026